PACLITAXEL FOR INJECTION 6 MG
PACLITAXEL : 6 MG · DIN 02296624 · PFIZER CANADA ULC
Health Canada status: CANCELLED POST MARKET
What is PACLITAXEL FOR INJECTION?
PACLITAXEL FOR INJECTION 6 MG contains PACLITAXEL : 6 MG. It is listed in the Health Canada Drug Product Database under DIN 02296624, held by PFIZER CANADA ULC, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 06-Apr-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02296624 |
|---|---|
| Brand name | PACLITAXEL FOR INJECTION |
| Generic / active ingredient | PACLITAXEL : 6 MG |
| Manufacturer | PFIZER CANADA ULC |
| Strength | 6 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Prescription |
| ATC code | L01CD01 PACLITAXEL |
| AHFS class | 68:12.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 06-Apr-2021 |
| Original market date | 2008-01-03 00:00:00 |
Is PACLITAXEL in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by ACCORD HEALTHCARE INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code L01CD01 PACLITAXEL. 5 of 19 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ABRAXANE FOR INJECTABLE SUSPENSION | 100 MG | POWDER FOR SUSPENSION | BRISTOL-MYERS SQUIBB CANADA | MARKETED | DIN 02281066 |
| PACLITAXEL FOR INJECTION | 6 MG | SOLUTION | BIOLYSE PHARMA CORPORATION | MARKETED | DIN 02244372 |
| PACLITAXEL INJECTION USP | 6 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02320150 |
| PACLITAXEL INJECTION USP | 6 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED | DIN 02391465 |
| PACLITAXEL POWDER FOR INJECTABLE SUSPENSION NANOPARTICLE, ALBUMIN-BOUND PACLITAXEL | 100 MG | POWDER FOR SUSPENSION | PANACEA BIOTEC PHARMA LIMITED | MARKETED | DIN 02496097 |
| AJ-PACLITAXEL | 6 MG | SOLUTION | AGILA JAMP CANADA INC | CANCELLED PRE MARKET | DIN 02409712 |
| APO-PACLITAXEL INJECTABLE | 6 MG | SOLUTION | APOTEX INC | DORMANT | DIN 02248844 |
| PACLITAXEL | 6 MG | LIQUID | IVAX PHARMACEUTICALS INCORPORATED | CANCELLED PRE MARKET | DIN 02241314 |
| PACLITAXEL FOR INJECTION | 6 MG | SOLUTION | TEVA CANADA LIMITED | APPROVED | DIN 02285363 |
| PACLITAXEL FOR INJECTION USP | 6 MG | SOLUTION | STERIMAX INC | DORMANT | DIN 02320010 |
Who else supplies PACLITAXEL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PACLITAXEL appears in 289 registered pack listings across 11 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.